DYNACIRC - 0173-0784-01 - (isradipine)

Alphabetical Index


Drug Information of DYNACIRC

Product NDC: 0173-0784
Proprietary Name: DYNACIRC
Non Proprietary Name: isradipine
Active Ingredient(s): 5    mg/1 & nbsp;   isradipine
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of DYNACIRC

Product NDC: 0173-0784
Labeler Name: GlaxoSmithKline LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020336
Marketing Category: NDA
Start Marketing Date: 20100104

Package Information of DYNACIRC

Package NDC: 0173-0784-01
Package Description: 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0173-0784-01)

NDC Information of DYNACIRC

NDC Code 0173-0784-01
Proprietary Name DYNACIRC
Package Description 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0173-0784-01)
Product NDC 0173-0784
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name isradipine
Dosage Form Name TABLET, FILM COATED, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20100104
Marketing Category Name NDA
Labeler Name GlaxoSmithKline LLC
Substance Name ISRADIPINE
Strength Number 5
Strength Unit mg/1
Pharmaceutical Classes Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient]

Complete Information of DYNACIRC


General Information